e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
Recruiting
N/A
Interventional Study
Cystic Fibrosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 6 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 60 (estimated)
- Sponsor
- University of Valencia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to analyse the impact of a telematic assessment and monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early, thus preventing loss of lung function and maintaining quality of life.
Participants will be assigned to one of 3 study groups:
Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group (T…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed cystic fibrosis
* Family access to an internet-enabled device
* Camera and microphone
* Absence of exacerbations in the last 30 days
Exclusion Criteria:
* Patients with lung transplant or on the waiting list for lung transplantation
* Previous eye surgery (3 months…
Contacts